The PE Ratio as of July 2024 (TTM) for Bio-Techne Corporation (TECH) is 64.48

According to Bio-Techne Corporation’s latest financial reports and current stock price. The company's current PE Ratio is 64.48. This represents a change of -1.42% compared to the average of 65.41 of the last 4 quarters.

Bio-Techne Corporation (TECH) Historical PE Ratio (quarterly & annually)

How has TECH PE Ratio performed in the past?

The mean historical PE Ratio of Bio-Techne Corporation over the last ten years is 55.13. The current 64.48 PE Ratio has changed 11.60% with respect to the historical average. Over the past ten years (40 quarters), TECH's PE Ratio was at its highest in in the June 2021 quarter at 292.76. The PE Ratio was at its lowest in in the December 2019 quarter at 17.51.

Bio-Techne Corporation (TECH) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Bio-Techne Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bio-Techne Corporation (TECH) Average PE Ratio

How has TECH PE Ratio performed in the past?

The current PE Ratio of Bio-Techne Corporation (TECH) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Bio-Techne Corporation (TECH) PE Ratio vs. Peers

How is TECH’s PE Ratio compared to its peers?

Bio-Techne Corporation’s PE Ratio is less than BioMarin Pharmaceutical Inc. (77.76), greater than Vaxcyte, Inc. (-21.49), greater than Liquidia Corporation (-8.14), greater than Legend Biotech Corporation (-22.11), greater than Seagen Inc. (-57.36), greater than Alnylam Pharmaceuticals, Inc. (-89.20), greater than Exelixis, Inc. (34.31), greater than Halozyme Therapeutics, Inc. (22.39), greater than Replimune Group, Inc. (-2.95), greater than Nuvalent, Inc. (-35.98), greater than Ventyx Biosciences, Inc. (-0.95), greater than Ascendis Pharma A/S (-13.97), greater than United Therapeutics Corporation (15.13), greater than Apellis Pharmaceuticals, Inc. (-11.71), greater than BeiGene, Ltd. (-28.09), greater than Akero Therapeutics, Inc. (-9.30), greater than Blueprint Medicines Corporation (-23.96), greater than Travere Therapeutics, Inc. (-4.73),

Build a custom stock screener for Bio-Techne Corporation (TECH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bio-Techne Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bio-Techne Corporation (TECH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bio-Techne Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.